AOBiome, LLC

AOBiome, LLC Financial Overview Background Formed: December 2012 Purchased Nitroceutic, LLC: January 2013 Began business operations: January 2013 Closed Series A-1 Preferred: January 2014, $931,338 Issuance of Series A-2 Preferred: March 2014, $470,877 Series B Terms Investment Amount to be raised: Security: Shares offered: Price per share: Pre-money valuation: Closing date: Preferences Series B Preferred Stock Series A and Founders Common and Incentive Shares Board Seats Series A Founders $4.0 million Series B Preferred Stock 2,666,667 $1.50 $20 million August 2014 Preference over all other classes $2,177,000 $0 1 L. Barshack 2 J. Heywood and W. Thompson Net Worth The Company's balance sheet at May 31, 2014 reflects the following approximate amounts: Total Asset at Fair Value: Total Liabilities: Preferred Stock: Net Worth: $ 223,739 ($204,000 cash) $ 105,826 $ 1,403,472 $ 117,913 The Company has an accumulated deficit of $1,252,538 as of May 31, 2014 and the year-to-date net loss as of May 31, 2014 of $486,405. EFTA01201095